Similarly, the positive prognostic effect of CD8 T cells was only observed in patients with high expression of HLA I, [20] and correction for HLA LOH improved the predictive utility of tumor mutation burden in response to PD1/PD-L1 blockade [21]. This evidence concerns the gene CD8A and neoplasm.